PELAIA, GIROLAMO
 Distribuzione geografica
Continente #
NA - Nord America 2.849
AS - Asia 1.179
EU - Europa 1.072
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
AF - Africa 4
Totale 5.137
Nazione #
US - Stati Uniti d'America 2.750
SG - Singapore 856
IT - Italia 630
CN - Cina 248
SE - Svezia 136
GB - Regno Unito 116
CA - Canada 96
DE - Germania 71
HK - Hong Kong 19
NL - Olanda 19
IN - India 18
FR - Francia 16
RU - Federazione Russa 15
FI - Finlandia 14
CZ - Repubblica Ceca 11
BR - Brasile 10
ES - Italia 8
IE - Irlanda 7
RO - Romania 7
AU - Australia 6
EU - Europa 5
ID - Indonesia 5
JP - Giappone 5
TW - Taiwan 5
AT - Austria 4
IR - Iran 4
PK - Pakistan 4
TR - Turchia 4
UA - Ucraina 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CL - Cile 3
IL - Israele 3
PT - Portogallo 3
CO - Colombia 2
HR - Croazia 2
MX - Messico 2
PE - Perù 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
MY - Malesia 1
OM - Oman 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 5.137
Città #
Chandler 573
Santa Clara 283
Singapore 276
Milan 241
Lawrence 227
Princeton 227
Wilmington 144
London 105
Chicago 98
Ottawa 91
Des Moines 71
Catanzaro 67
Ashburn 57
Shanghai 30
Boardman 27
Guangzhou 19
Redwood City 19
Norwalk 18
Hong Kong 17
Rome 17
Beijing 16
Hanover 16
Naples 16
Palermo 16
San Nicola Manfredi 16
Redmond 15
Troina 15
Seattle 12
Helsinki 11
Olomouc 11
Munich 10
Florence 9
Pune 9
Shenzhen 9
Augusta 7
Dublin 7
Falls Church 7
Rogliano 7
Wuhan 7
Assago 6
Bologna 6
Council Bluffs 6
Ferrara 6
Mountain View 6
Padova 6
Paris 6
Salerno 6
Wuxi 6
Jiaxing 5
Quanzhou 5
Shenyang 5
Turin 5
Ann Arbor 4
Aversa 4
Cherasco 4
Crotone 4
Horia 4
Lamezia Terme 4
Los Angeles 4
Providence 4
Rende 4
Rui'an 4
San Mateo 4
Taipei 4
Afragola 3
Aiello Calabro 3
Amsterdam 3
Ankara 3
Brookline 3
Curitiba 3
Genoa 3
Houston 3
Jinan 3
Kemerovo 3
Muggiò 3
Sanming 3
Taranto 3
Wake Forest 3
Anzio 2
Bogotá 2
Buffalo 2
Campobasso 2
Clearwater 2
Cosenza 2
Covent Garden 2
Cupertino 2
Dalian 2
Delhi 2
Fara in Sabina 2
Fisciano 2
Foggia 2
Foshan 2
Girona 2
Hangzhou 2
Jinhua 2
Lecco 2
Legnano 2
Lima 2
Madrid 2
Marseille 2
Totale 3.031
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 64
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 58
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 57
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 52
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 50
Application of proteomics and peptidomics to COPD 47
Asthma and COPD proteomics: Current approaches and future directions 46
High-flow nasal oxygen therapy in intensive care and anaesthesia 44
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 43
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 42
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 42
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 39
A case of alveolar proteinosis associated with pulmonary nocardiosis 39
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 38
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 38
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 36
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 35
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 35
Treatment of COPD by dual bronchodilation with co-formulation of indacaterol/glycopyrronium 34
The severe asthma network in Italy: findings and perspectives 34
Adverse drug reactions in hospitalized patients following NSAIDs administration 34
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 34
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 33
Enfisema polmonare 33
Adverse drug reactions in hospitalized patients following antibiotics administration 33
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 33
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 33
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 33
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 33
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 33
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 33
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 32
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 31
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 31
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 31
Applicazioni della Biologia Molecolare alle Malattie Respiratorie 31
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 31
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 31
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 30
Airways smooth muscle response to biological stimuli 30
I beta2-adrenergici 30
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 30
Anticolinergici 30
Patogenesi e terapia dell’asma bronchiale: recenti acquisizioni, 30
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 30
null 30
Bronchial asthma induced by an antithyroid drug 29
Agonisti beta2-adrenergici 29
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 29
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 29
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 29
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 29
Alpha-interferon and its effects on signal transduction pathways 28
VIP: a new promising marker for AECOPD or a fashionable marker soon forgotten? 28
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 28
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 28
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells 27
Dupilumab: a novel treatment for asthma 27
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 27
Oxidative Stress and Respiratory Disease 27
Adverse drug reactions in hospitalized patients following bronchodilators administration 27
Omalizumab riduce la frequenza delle riacutizzazioni, l’assunzione orale di corticosteroidi e l’eosinofilia ematica in pazienti atopici con asma cronico severo 27
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma 27
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 27
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 27
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 27
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 27
Exhaled nitric oxide during humming: potential clinical tool in sinonasal disease? 26
Effects of transforming growth factor-beta and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 26
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 26
Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine 26
Role of biologics in severe eosinophilic asthma - focus on reslizumab 26
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma 26
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 26
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 26
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review 25
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 25
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 25
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 25
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 25
Respiratory infections and asthma 24
Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics 24
Antimuscarinici 24
III. Biologia molecolare della recezione e della trasduzione dei segnali 24
Basi biomolecolari delle pneumopatie interstiziali: Azione degli steroidi sul rilascio delle citochine 24
Effects of MAPK inhibitors on H2O2-induced IL-8 production and cell death in primary cultures of human bronchial epithelial cells 24
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 24
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 24
Effects of specific immunotherapy in bronchial hyperresponsiveness 23
New perspectives in asthma treatment 23
Nitric oxide in upper airways inflammatory diseases 23
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 23
I CORTICOSTEROIDI 23
Azioni degli steroidi sul rilascio delle citochine 23
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 23
Effect of TGF-beta and budesonide an MAPK activatin and apoptosis in airway epithelial cells 23
Valutazione comparativa dell’effetto protettivo del broxaterolo e del salbutamolo nei confronti del broncospasmo indotto da nebbia ultrasonica di acqua distillata 23
Early management of COPD: where are we now and where do we go from here? 23
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma 23
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 23
Totale 3.080
Categoria #
all - tutte 83.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 0 0 0 0 0 4 19 105
2020/2021243 27 2 7 33 24 13 7 6 86 25 6 7
2021/2022584 4 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20251.944 412 137 97 105 196 345 93 75 351 133 0 0
Totale 5.365